Ore. Says McKesson Artificially Inflated Drug Prices

Law360, New York (November 09, 2011, 4:56 PM ET) -- The state of Oregon on Monday sued McKesson Corp. in California federal court, claiming the drug distributor conspired to artificially inflate average wholesale drug prices, costing taxpayers millions in higher Medicaid reimbursements.

Oregon claims McKesson, the nation's largest pharmaceutical wholesaler, unlawfully inflated the published average wholesale prices for hundreds of brand name drugs — including Advair, Allegra, Celebrex, Flonase, Lipitor and Zyprexa.

The state says the price inflation scheme devised by McKesson and drug price publisher First DataBank Inc. caused pharmacies and other providers to submit...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required